| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
2,187 |
2,187 |
98,220 |
| Total Buy Value |
$0 |
$38,963 |
$38,963 |
$2,585,297 |
| Total People Bought |
0 |
1 |
1 |
2 |
| Total Buy Transactions |
0 |
1 |
1 |
4 |
| Total Shares Sold |
100 |
200 |
8,325 |
31,716 |
| Total Sell Value |
$2,787 |
$4,692 |
$233,035 |
$1,293,892 |
| Total People Sold |
1 |
1 |
2 |
3 |
| Total Sell Transactions |
1 |
2 |
6 |
12 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nishar Dipchand |
Director |
– • – |
2019-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
330 |
2,292 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-08-26 |
4 |
AS |
$94.05 |
$50,599 |
D/D |
(538) |
1,302 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-08-26 |
4 |
OE |
$4.18 |
$2,249 |
D/D |
538 |
1,840 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-26 |
4 |
AS |
$92.26 |
$1,253,791 |
I/I |
(13,432) |
9,784 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-26 |
4 |
AS |
$92.26 |
$445,283 |
D/D |
(4,770) |
1,454 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-26 |
4 |
OE |
$4.18 |
$19,734 |
D/D |
4,721 |
6,224 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-26 |
4 |
AS |
$92.27 |
$57,795 |
I/I |
(618) |
9,523 |
|
- |
|
| Kaul Samir |
Director |
– • – |
2019-08-23 |
4 |
A |
$0.00 |
$0 |
I/I |
13,754 |
15,159 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-23 |
4 |
AS |
$94.79 |
$2,549,900 |
I/I |
(26,407) |
9,880 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-23 |
4 |
AS |
$98.78 |
$203,502 |
D/D |
(2,058) |
1,503 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-23 |
4 |
AS |
$94.79 |
$661,014 |
D/D |
(6,895) |
3,561 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-23 |
4 |
OE |
$4.18 |
$37,056 |
D/D |
8,865 |
10,456 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-22 |
4 |
AS |
$96.29 |
$3,349,583 |
I/I |
(34,215) |
10,556 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-22 |
4 |
AS |
$96.29 |
$1,136,110 |
D/D |
(11,605) |
1,591 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-22 |
4 |
OE |
$4.18 |
$48,024 |
D/D |
11,489 |
13,196 |
|
- |
|
| Hilaly Aaref |
Director |
– • – |
2019-08-21 |
4 |
A |
$0.00 |
$0 |
I/I |
16,373 |
32,746 |
|
- |
|
| Nishar Dipchand |
Director |
– • – |
2019-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
330 |
1,962 |
|
- |
|
| Bertocci Derek A |
Chief Financial Officer |
• – – |
2019-08-19 |
4 |
AS |
$98.85 |
$4,254,781 |
D/D |
(42,548) |
84,962 |
|
- |
|
| Bertocci Derek A |
Chief Financial Officer |
• – – |
2019-08-19 |
4 |
OE |
$3.63 |
$99,999 |
D/D |
27,548 |
127,510 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-16 |
4 |
AS |
$100.42 |
$5,615,974 |
I/I |
(55,763) |
11,428 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-16 |
4 |
AS |
$100.43 |
$1,904,765 |
D/D |
(18,913) |
1,707 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-08-16 |
4 |
OE |
$4.18 |
$78,275 |
D/D |
18,726 |
20,620 |
|
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2019-08-16 |
4 |
AS |
$100.82 |
$5,344,208 |
D/D |
(53,000) |
208,737 |
|
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2019-08-16 |
4 |
OE |
$4.18 |
$125,400 |
D/D |
30,000 |
261,737 |
|
- |
|
| Eltoukhy Helmy |
Chief Executive Officer |
• • – |
2019-08-16 |
4 |
AS |
$100.40 |
$16,793,241 |
D/D |
(166,095) |
3,524,565 |
|
- |
|
707 Records found
|
|
Page 25 of 29 |
|
|
